Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Infusion chemotherapy with cisplatinum and fluorouracil in the treatment of locally-advanced and metastatic gallbladder cancer

Chatni S S, Sainani R S, Mehta S A, Mohandas K M

Year : 2008| Volume: 4| Issue : 4 | Page no: 151-155

   This article has been cited by
 
1 Recent advances in systemic therapies and radiotherapy for gallbladder cancer
Charles Henry Caldow Pilgrim,Ryan T. Groeschl,Edward J. Quebbeman,T. Clark Gamblin
Surgical Oncology. 2013; 22(1): 61
[Pubmed]  [Google Scholar] [DOI]
2 Biliary tract carcinomas: From chemotherapy to targeted therapy
Donatella Marino,Francesco Leone,Giuliana Cavalloni,Celeste Cagnazzo,Massimo Aglietta
Critical Reviews in Oncology/Hematology. 2013; 85(2): 136
[Pubmed]  [Google Scholar] [DOI]
3 A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer
Sang Myung Woo,Sang Hyub Lee,Ji Won Yoo,Ki Young Yang,Jung Gyun Seo,Joo Kyung Park,Jin-Hyeok Hwang,Woo Jin Lee,Ji Kon Ryu,Yong-Tae Kim,Yong Bum Yoon
Gut and Liver. 2013; 7(5): 594
[Pubmed]  [Google Scholar] [DOI]
4 Recent advances in systemic therapies and radiotherapy for gallbladder cancer
Caldow Pilgrim, C.H. and Groeschl, R.T. and Quebbeman, E.J. and Gamblin, T.C.
Surgical Oncology. 2013; 22(1): 61-67
[Pubmed]  [Google Scholar]
5 Biliary tract carcinomas: From chemotherapy to targeted therapy
Marino, D. and Leone, F. and Cavalloni, G. and Cagnazzo, C. and Aglietta, M.
Critical Reviews in Oncology/Hematology. 2013; 85(2): 136-148
[Pubmed]  [Google Scholar]
6 PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females
Rajani Rai,Kiran L. Sharma,Sanjeev Misra,Ashok Kumar,Balraj Mittal
Gene. 2013; 530(2): 172
[Pubmed]  [Google Scholar] [DOI]
7 Palliative treatment for locally advanced or metastatic gallbladder cancer: Conclusions of the Latin American Consensus meeting for the management of gallbladder cancer [Manejo paliativo del cáncer de vesícula biliar irresecable o metastásico: Conclusiones del Consenso Latinoamericano de Manejo del Cáncer de Vesícula Biliar]
Müller, B. and Arroyo, G. and Gallardo, J. and Villanueva, L. and González, P. and Baeza, R. and de Aretxabala, X. and Maluenda, F. and Acevedo, A. and Chuecas, F. and Díaz, J.C. and César García, S. and Reyes, J.M. and Navarrete, C.
Revista Medica de Chile. 2011; 139(2): 267-273
[Pubmed]  [Google Scholar]
8 Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer
Jian Dong Wang, Wei Bin Shi, Jun Shen, Peng Yuan Zhuang, Zhi Wei Quan, Xue Feng Wang, Xue Ping Zhou, Song Gang Li, Ying Bin Liu, Yong Yang
Medical Oncology. 2010;
[HTML Full text]  [Google Scholar] [DOI]
9 Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials
Wagner, A.D., Buechner-Steudel, P., Moehler, M., Schmalenberg, H., Behrens, R., Fahlke, J., Wein, A., Fleig, W.E.
British Journal of Cancer. 2009; 101(11): 1846-1852
[Pubmed]  [Google Scholar] [DOI]

 

Read this article